These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 23385241)

  • 41. Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study.
    Zakerska-Banaszak O; Tomczak H; Gabryel M; Baturo A; Wolko L; Michalak M; Malinska N; Mankowska-Wierzbicka D; Eder P; Dobrowolska A; Slomski R; Skrzypczak-Zielinska M
    Sci Rep; 2021 Jan; 11(1):2166. PubMed ID: 33495479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis.
    Magnusson MK; Strid H; Isaksson S; Simrén M; Öhman L
    Inflamm Bowel Dis; 2017 Jun; 23(6):956-966. PubMed ID: 28445247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alteration of Fungal Microbiota After 5-ASA Treatment in UC Patients.
    Jun X; Ning C; Yang S; Zhe W; Na W; Yifan Z; Xinhua R; Yulan L
    Inflamm Bowel Dis; 2020 Feb; 26(3):380-390. PubMed ID: 31750918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis.
    Fukuda K; Fujita Y
    BMC Gastroenterol; 2014 Mar; 14():49. PubMed ID: 24641276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease.
    Gosiewski T; Strus M; Fyderek K; Kowalska-Duplaga K; Wedrychowicz A; Jedynak-Wasowicz U; Sladek M; Pieczarkowski S; Adamski P; Heczko PB
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):20-7. PubMed ID: 21788912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease.
    Sha S; Xu B; Wang X; Zhang Y; Wang H; Kong X; Zhu H; Wu K
    Diagn Microbiol Infect Dis; 2013 Mar; 75(3):245-51. PubMed ID: 23276768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
    Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY
    Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term safety and tolerability of once-daily mesalamine granules in the maintenance of remission of ulcerative colitis.
    Lichtenstein GR; Barrett AC; Bortey E; Paterson C; Forbes WP
    Inflamm Bowel Dis; 2014 Aug; 20(8):1399-406. PubMed ID: 24874460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response.
    Haberman Y; Karns R; Dexheimer PJ; Schirmer M; Somekh J; Jurickova I; Braun T; Novak E; Bauman L; Collins MH; Mo A; Rosen MJ; Bonkowski E; Gotman N; Marquis A; Nistel M; Rufo PA; Baker SS; Sauer CG; Markowitz J; Pfefferkorn MD; Rosh JR; Boyle BM; Mack DR; Baldassano RN; Shah S; Leleiko NS; Heyman MB; Grifiths AM; Patel AS; Noe JD; Aronow BJ; Kugathasan S; Walters TD; Gibson G; Thomas SD; Mollen K; Shen-Orr S; Huttenhower C; Xavier RJ; Hyams JS; Denson LA
    Nat Commun; 2019 Jan; 10(1):38. PubMed ID: 30604764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular-phylogenetic characterization of the microbiota in ulcerated and non-ulcerated regions in the patients with Crohn's disease.
    Li Q; Wang C; Tang C; Li N; Li J
    PLoS One; 2012; 7(4):e34939. PubMed ID: 22529960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.
    Scaldaferri F; Gerardi V; Mangiola F; Lopetuso LR; Pizzoferrato M; Petito V; Papa A; Stojanovic J; Poscia A; Cammarota G; Gasbarrini A
    World J Gastroenterol; 2016 Jun; 22(24):5505-11. PubMed ID: 27350728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa.
    Reshef L; Kovacs A; Ofer A; Yahav L; Maharshak N; Keren N; Konikoff FM; Tulchinsky H; Gophna U; Dotan I
    Gastroenterology; 2015 Sep; 149(3):718-27. PubMed ID: 26026389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM Study.
    Nagahori M; Kochi S; Hanai H; Yamamoto T; Nakamura S; Omuro S; Watanabe M; Hibi T;
    BMC Gastroenterol; 2017 Apr; 17(1):47. PubMed ID: 28390410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.
    Kunde S; Pham A; Bonczyk S; Crumb T; Duba M; Conrad H; Cloney D; Kugathasan S
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):597-601. PubMed ID: 23542823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of fecal and mucosa-associated microbiota in Chinese patients with inflammatory bowel disease.
    Chen L; Wang W; Zhou R; Ng SC; Li J; Huang M; Zhou F; Wang X; Shen B; A Kamm M; Wu K; Xia B
    Medicine (Baltimore); 2014 Aug; 93(8):e51. PubMed ID: 25121355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Composition and diverse differences of intestinal microbiota in ulcerative colitis patients.
    Zhu S; Han M; Liu S; Fan L; Shi H; Li P
    Front Cell Infect Microbiol; 2022; 12():953962. PubMed ID: 36111238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Situ Profiling of the Three Dominant Phyla Within the Human Gut Using TaqMan PCR for Pre-Hospital Diagnosis of Gut Dysbiosis.
    Jo YJ; Tagele SB; Pham HQ; Jung Y; Ibal JC; Choi S; Kang GU; Park S; Kang Y; Kim S; Koh H; Shin JH
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis.
    Varela E; Manichanh C; Gallart M; Torrejón A; Borruel N; Casellas F; Guarner F; Antolin M
    Aliment Pharmacol Ther; 2013 Jul; 38(2):151-61. PubMed ID: 23725320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis.
    D'Haens G; Sandborn WJ; Barrett K; Hodgson I; Streck P
    Am J Gastroenterol; 2012 Jul; 107(7):1064-77. PubMed ID: 22565161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission.
    Martinez C; Antolin M; Santos J; Torrejon A; Casellas F; Borruel N; Guarner F; Malagelada JR
    Am J Gastroenterol; 2008 Mar; 103(3):643-8. PubMed ID: 18341488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.